Superconductivity

pp.16 Date: May 30,1994 H. Takagi, R.J. Cava, M. Marezio, B. Batlogg, J.J. Krajewski, W.F. Peck, Jr., P. Bordet, D.E. Cox, "Disappearance of superconductivity in overdoped La2- xSrxCuO4 at a structural phase boundary," Physical Review Letters, 68:3777-80, 1992. Robert J. Cava (AT&T Bell Laboratories, Murray Hill, N.J.): "One of the obstacles to understanding the still-elusive underlying cause of high-Tc superconductivity is the fi


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

pp.16
Date: May 30,1994

H. Takagi, R.J. Cava, M. Marezio, B. Batlogg, J.J. Krajewski, W.F. Peck, Jr., P. Bordet, D.E. Cox, "Disappearance of superconductivity in overdoped La2- xSrxCuO4 at a structural phase boundary," Physical Review Letters, 68:3777-80, 1992.

Robert J. Cava (AT&T Bell Laboratories, Murray Hill, N.J.): "One of the obstacles to understanding the still-elusive underlying cause of high-Tc superconductivity is the finding of a `model system' in which the physical properties are clear-cut, well-characterized, and undisputed. Although more than 30 distinct copper oxide ceramics are now known to be superconducting at high temperatures, virtually all are so complex--either chemically or electron- ically--that they are useless for providing the kinds of fundamental information that theorists need as an anchor for their thinking. Strontium-doped La2CuO4, one of the first copper oxide-based superconductors discovered, and the subject of our publication, is widely considered to be the simplest high-Tc superconductor known.

"La2CuO4 itself ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo